✦ LIBER ✦

Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma

✍ Scribed by Fakhrai, H; Mantil, J C; Liu, L; Nicholson, G L; Murphy-Satter, C S; Ruppert, J; Shawler, D L

Book ID: 110019375
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 272 KB
Volume: 13
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700975

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of Belagenpumatucel-L, a

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

✍ Nemunaitis, J; Nemunaitis, M; Senzer, N; Snitz, P; Bedell, C; Kumar, P; Pappen, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

Results of a phase I clinical trial of v

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells

✍ Tetsuro Kikuchi; Yasuharu Akasaki; Masaki Irie; Sadamu Homma; Toshiaki Abe; Tsun 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 208 KB

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

A phase I trial of perillyl alcohol in p

A phase I trial of perillyl alcohol in patients with advanced solid tumors

✍ Christopher G. Azzoli; Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; David R. S 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 232 KB

A phase I trial of gemcitabine in combin

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

✍ William Schelman; Sherry Morgan-Meadows; Howard Bailey; Kyle Holen; James P. Tho 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 325 KB

Monitoring tumor antigen specific T-cell

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

✍ Pedro Romero; Jean-Charles Cerottini; DanielE. Speiser 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 198 KB